Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Administrative Law (1)
- Agriculture Law (1)
- Antitrust and Trade Regulation (1)
- Civil Law (1)
- Commercial Law (1)
-
- Comparative and Foreign Law (1)
- Conflict of Laws (1)
- Constitutional Law (1)
- Courts (1)
- Dispute Resolution and Arbitration (1)
- Environmental Law (1)
- First Amendment (1)
- Fourteenth Amendment (1)
- Government Contracts (1)
- Health Law and Policy (1)
- Human Rights Law (1)
- Intellectual Property Law (1)
- International Law (1)
- Internet Law (1)
- Jurisdiction (1)
- Publication
Articles 1 - 2 of 2
Full-Text Articles in Insurance Law
Gandhi’S Prophecy: Corporate Violence And A Mindful Law For Bhopal, Nehal A. Patel
Gandhi’S Prophecy: Corporate Violence And A Mindful Law For Bhopal, Nehal A. Patel
Nehal A. Patel
AbstractOver thirty years have passed since the Bhopal chemical disaster began,and in that time scholars of corporate social responsibility (CSR) havediscussed and debated several frameworks for improving corporate responseto social and environmental problems. However, CSR discourse rarelydelves into the fundamental architecture of legal thought that oftenbuttresses corporate dominance in the global economy. Moreover, CSRdiscourse does little to challenge the ontological and epistemologicalassumptions that form the foundation for modern economics and the role ofcorporations in the world.I explore methods of transforming CSR by employing the thought ofMohandas Gandhi. I pay particular attention to Gandhi’s critique ofindustrialization and principle of swadeshi (self-sufficiency) …
Waging War On Specialty Pharmaceutical Tiering In Pharmacy Benefit Design, Chad I. Brooker
Waging War On Specialty Pharmaceutical Tiering In Pharmacy Benefit Design, Chad I. Brooker
Chad I Brooker
Specialty drugs represent a growing concern for both health insurance issuers and beneficiaries given their exceedingly high (and growing) costs—representing almost half of all drug spend by 2017. Payers have sought to reduce their specialty drug spend by sharing more of the cost of these drugs with the beneficiaries who depend on them through the creation of specialty drug tiers. This has forced some patients to choose between forgoing other needs to pay for their medications or not take them at all. While several states have sought to outlaw the use of specialty drug tiers or limit pharmaceutical OOP cost-sharing, …